Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Beletsi, A"'
Publikováno v:
In Value in Health Regional Issues July 2023 36:58-65
Publikováno v:
Value in Health Regional Issues. 36:58-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b17dab9c33b64b78e85f8792ed218abb
https://doi.org/10.1016/j.vhri.2023.03.001
https://doi.org/10.1016/j.vhri.2023.03.001
Publikováno v:
In Value in Health Regional Issues September 2018 16:81-91
Autor:
George Gourzoulidis, Maria Koulentaki, Antonis Kattamis, Maria Bouzani, Chara Giatra, Vassiliki Chotzagiannoglou, Alexandra Beletsi, Georgia Kourlaba
Publikováno v:
Clinical Drug Investigation. 42:999-1008
Acute lymphoblastic leukemia (ALL) is an acute, rapidly progressing and life-threatening form of cancer involving immature lymphocytes called lymphoblasts. ALL is the most common subtype of leukemia in children and adolescents. The aim of the present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d954c6e879095a1416727fbe2f04d4e2
https://doi.org/10.1007/s40261-022-01207-w
https://doi.org/10.1007/s40261-022-01207-w
Autor:
George Gourzoulidis, Maria Koulentaki, Antonis Kattamis, Maria Bouzani, Chara Giatra, Vassiliki Chotzagiannoglou, Alexandra Beletsi, Georgia Kourlaba
Publikováno v:
Clinical Drug Investigation. 43:151-151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f45eae351905380b2e9d5c2257fef6a
https://doi.org/10.1007/s40261-022-01236-5
https://doi.org/10.1007/s40261-022-01236-5
Publikováno v:
Value in Health. 25:S138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed265580cbfa33179679995f2134aade
https://doi.org/10.1016/j.jval.2022.09.664
https://doi.org/10.1016/j.jval.2022.09.664
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alexandra Beletsi, Georgia Kourlaba
Background: To present the outcome of the Health Technology Assessment (HTA) process in Greece from its onset back in July 2018 till January 2021 and to quantify the median time from marketing authorization (MA) to listing especially for new medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a44c9ac55d631b0a9f8b199abc3d7165
https://doi.org/10.21203/rs.3.rs-641812/v1
https://doi.org/10.21203/rs.3.rs-641812/v1
Autor:
Nikolaos Androulakis, Anna Koumarianou, Georgia Kourlaba, Alexandra Beletsi, Maria Koulentaki, Spyridon Xynogalos, Ioannis Boukovinas, John Souglakos, Michalis V. Karamouzis, Pavlos Papakotoulas, Vasiliki Chotzagiannoglou, G Gourzoulidis, Epaminondas Samadas
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 22(2)
Objective: To evaluate the cost-effectiveness of trifluridine/tipiracil (FTD/TPI) compared with best supportive care (BSC) for the treatment of patients with metastatic gastric cancer(mGC), including gastroesophageal junction adenocarcinoma(GEJ), who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278672e9c31376babcba9936364645e3
https://pubmed.ncbi.nlm.nih.gov/33900864
https://pubmed.ncbi.nlm.nih.gov/33900864
Objective: To evaluate the cost-effectiveness of trifluridine/tipiracil (FTD/TPI) compared with best supportive care (BSC) for the treatment of patients with metastatic gastric cancer(mGC), including gastroesophageal junction adenocarcinoma(GEJ), who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::01610c1dca27443795053c40cc6e26e9
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120217
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120217